A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

NCT02111252 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda